Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugate.
Wei XiangYongbo PengHongliang ZengChunping YuQun ZhangBiao LiuJiahao LiuXing HuWensu WeiMinhua DengNing WangXuewen LiuJianfei XieWeibin HouJin TangZhi LongLong WangJianye LiuPublished in: Biomaterials research (2022)
These results demonstrated that PTK7-GEMs is a successful targeted aptamer-drug conjugates strategy (APDCs) to treat BC, which will provide new directions for the precision treatment of BC in the field of biomarker-oriented tumor targeted therapy.